FDA
-
-
-
-
-
-
-
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
-
-
-
-
-
-
-
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinica
-
-
-
-
-
-
-
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
-
-
-
-
-
-
-
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
-
-
-
-
-
-
-
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
-
-
-
-
-
-
-
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
-
-
-
-
-
-
-
Cerus (CERS) Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
-
326,551 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

